Author

L. Daly

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

G. Kimura· 1 shared G. Rapeport· 1 shared H. Ombredane· 1 shared I. ITO· 1 shared I. Knowles· 1 shared J. Baker· 1 shared K. A. Lucas· 1 shared K. Ito· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

G. Kimura

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice

J. Baker, H. Ombredane, L. Daly, I. Knowles, G. Rapeport, I. ITO

This study shows that PIKfyve inhibitors reduce viral load and inflammation in respiratory virus infections in human epithelium and mice, suggesting their potential as broad-spectrum antivirals.

bioRxiv · Aug 11, 2023Microbiology

Antifungal effects of PC945, a novel inhaled triazole, on Candida albicans-infected immunocompromised mice

N. Yuki, K. Ito, G. Kimura, K. A. Lucas, L. Daly, P. Strong, K. Yasuo

This study evaluates the antifungal effects of PC945, a novel inhaled triazole, against Candida albicans in immunocompromised mice, showing improved survival and reduced fungal load compared to voriconazole.

bioRxiv · Jul 27, 2020 · PreprintPharmacology & Toxicology